Clinical Evaluation of the APTIMA® HPV Assay Using the PANTHER™ System

计划入组 11,816 人 · 首次发布于 2011 年 10 月 5 日

Clinical Evaluation of the APTIMA® HPV Assay Using the TIGRIS® System

计划入组 12,896 人 · 首次发布于 2009 年 9 月 9 日

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

计划入组 10,000 人 · 首次发布于 2015 年 12 月 17 日

HPV-X

HPV CD40 HVac

SQZ-PBMC-HPV

DYNAMIC ACTIVE TACTICAL BOND ETF UNITS

Olink Holding AB

Sweden

Merck & Co Inc

United States

Hologic's Aptima HPV Assay Receives FDA Approval for Primary Cervical Cancer Screening

OM1's AI Platform Enables Landmark 650,000-Patient Real-World Evidence Study Supporting FDA Approval of Hologic's HPV Screening Assay

HPV cfDNA Demonstrates 95% Sensitivity for Detecting HPV-Driven Oropharyngeal Cancer and Predicts Recurrence Months Before Imaging